Development of a biochemical diagnosis for creutzfeldt-jakob disease
Ended Project Grant Awarded Last action
- Award ID
- R42NS079060
- Recipient
-
Amprion, Inc. UEI QBCELFPYPNJ3
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,169,312
Award facts
- Assistance listing
- 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
- Completion date
- Originally
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- Place of performance
- Houston, TX 77019, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $501,426 | |
| Amendment | $473,316 | |
| Amendment | $29,027 | |
| Original award | $165,543 |
Quick answers
Who received award R42NS079060?
R42NS079060 was awarded to Amprion, Inc. by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on September 1, 2013.
How much is award R42NS079060 worth?
$1,169,312 has been obligated on R42NS079060.
Which agency awarded R42NS079060?
National Institute of Neurological Disorders and Stroke (National Institutes of Health) awarded R42NS079060, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award